Top Five Small-Cap Stocks: Balchem
Exponent has been rated a buy since November 2001. An impressive record of EPS growth and compelling growth in net income are some of the company's strengths. For the first quarter of fiscal 2008, revenue rose 15% year over year. Net income for the same period increased 26% to $6.4 million. Exponent reported that EPS improved 29% to 40 cents in the most recent quarter. In fact, the company has demonstrated a pattern of positive EPS growth over the past two years. Finally, return on equity improved slightly from the year-ago quarter.
Driven by earnings growth of 29%, this stock has surged 58% over the past year. We feel that Exponent should continue to climb despite its already impressive performance. The company believes that it remains well positioned to capture new opportunities for growth as it moves further into fiscal 2008. For the full year, management expects to report high single-digit to low double-digit growth in revenue as a result of the company's plans to pursue strategic opportunities. However, Exponent's future results could be negatively impacted by any disruptive changes in both general and industry-specific economic conditions and the effects of tort reform and government regulation of the company's business.
American Physicians Capital (ACAP) is an insurance holding company. Its primary focus is medical professional liability insurance, which it writes through its subsidiary, American Physicians Assurance Corporation. The company underwrites policies for physicians, their corporations, medical groups, clinics and ancillary health care providers. Medical professional liability insurance covers physicians and other health care providers against liabilities arising from providing or failing to provide professional medical services. American Physicians' main office is located in Michigan, and the company markets its coverage in that state, as well as Illinois, Wisconsin, Indiana, New Mexico, Kentucky and Ohio. The company was founded in 1975.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV